|

LLY U.S.: NYSE

Eli Lilly & Co.

Watchlist

LLYUS

Premarket

Last Updated: Sep 8, 2023 4:55 a.m. EDT Delayed quote

^$ 578.40

5.17

0.90%

Before Hours Volume:

638

Close	Chg	Chg %
$573.23	13.28	2.37%

Advanced Charting

136% vs Avg

Partner Center

Your Watchlists

Customize MarketWatch

Have Watchlists? Log in to see them here or sign up to get started.

Create Account … or Log In

	Symbol Company	Price Chg/Chg %

(Go to Your Watchlist)

No Items in Watchlist

There are currently no items in this Watchlist.

Add Tickers

No Saved Watchlists

Create a list of the investments you want to track.

Create Watchlist …or learn more

Uh oh

Something went wrong while loading Watchlist.

Go to Watchlist

Recently Viewed Tickers

No Recent Tickers

Visit a quote page and your recently viewed tickers will be displayed here.

Overview

Profile

Charts

Financials

Historical Quotes

Analyst Estimates

Options

Open $564.19
Day Range 562.62 - 576.31
52 Week Range 296.32 - 576.31
Market Cap $531.56B
Shares Outstanding 949.3M
Public Float 847.33M
Beta 0.62
Rev. per Employee $756.81K
P/E Ratio 80.88
EPS $7.09
Yield 0.79%
Dividend $1.13
Ex-Dividend Date Aug 14, 2023
Short Interest 5.19M 08/15/23
% of Float Shorted 0.61%
Average Volume 2.73M

5 Day	2.89%
1 Month	8.51%
3 Month	28.52%
YTD	56.69%
1 Year	80.43%

Sell
Under
Hold
Over
Buy

Number of Ratings 28 Full Ratings

Read full story

Eli Lilly & Co. stock outperforms market on strong trading day

Sep. 7, 2023 at 4:33 p.m. ET by MarketWatch Automation

Read full story

Biotech and Pharma Weight-Loss Drug Market Can Hit $100 Billion, J.P. Morgan Says. That Makes Eli Lilly Stock a Big Winner.

Sep. 7, 2023 at 11:39 a.m. ET by Barron's

Read full story

Eli Lilly & Co. stock outperforms competitors on strong trading day

Sep. 6, 2023 at 4:33 p.m. ET by MarketWatch Automation

Read full story

Eli Lilly & Co. stock outperforms market on strong trading day

Sep. 5, 2023 at 4:33 p.m. ET by MarketWatch Automation

Read full story

Biotech and Pharma Novo Nordisk Is Now Europe’s Biggest Company, Driven by Weight-Loss Drug. How Eli Lilly Could Benefit.

Sep. 5, 2023 at 5:43 a.m. ET by Barron's

Read full story

Eli Lilly & Co. stock outperforms competitors on strong trading day

Sep. 1, 2023 at 4:34 p.m. ET by MarketWatch Automation

Read full story

Dividends Global Dividends Hit a Record High, Driven by Banks

Aug. 30, 2023 at 12:01 a.m. ET by Barron's

Read full story

Biotech and Pharma Eli Lilly and Other Pharma Stocks Are Ignoring Medicare’s 10 Drug List

Aug. 29, 2023 at 3:26 p.m. ET by Barron's

Read full story

Eliquis, Jardiance among first 10 drugs selected for Medicare price negotiations

Aug. 29, 2023 at 3:22 p.m. ET by Eleanor Laise

Read full story

Biotech and Pharma Biden Administration to Reveal Which Pharma Blockbusters Medicare Will Pay Less For

Aug. 28, 2023 at 3:00 a.m. ET by Barron's

Read full story

These 20 dividend stocks have been the best income growers in the S&P 500

Aug. 22, 2023 at 9:45 a.m. ET by Philip van Doorn

Eli Lilly reports positive results from study of thyroid cancer treatment

Aug. 22, 2023 at 8:32 a.m. ET by Eleanor Laise

Amazon Pharmacy launches automatic coupons for $35 insulin

Aug. 15, 2023 at 9:07 a.m. ET by Eleanor Laise

Read full story

Markets The Inflation Numbers Were Good. Why the Fed Still Won’t Be Happy.

Aug. 11, 2023 at 6:14 a.m. ET

Read full story

Biotech and Pharma Eli Lilly Rises Again as Stock Upgraded Following Mounjaro Sales Surge

Aug. 9, 2023 at 12:36 p.m. ET by Barron's

Eli Lilly’s stock gains 0.1% premarket, after soaring 14.9% on Tuesday to a record close

Aug. 9, 2023 at 7:57 a.m. ET by Tomi Kilgore

Eli Lilly stock price target raised to $600 from $510 at J.P. Morgan

Aug. 9, 2023 at 7:19 a.m. ET by Tomi Kilgore

Read full story

Biotech and Pharma For Dieters, Obesity Drugs Are a Magic Pill. Snack Makers Might Be the Real Losers.

Aug. 9, 2023 at 2:00 a.m. ET by Barron's

Read full story

Dow ends down 160 points after weak China data, Moody’s downgrade on regional banks

Aug. 8, 2023 at 4:32 p.m. ET by William Watts

Read full story

Biotech and Pharma Eli Lilly Stock Is Flying After Strong Results. Obesity Drugs Delivered the Goods.

Aug. 8, 2023 at 10:26 a.m. ET by Barron's

No Headlines Available

Unveiling Eli Lilly and Co (LLY)'s Value: Is It Really Priced Right? A Comprehensive Guide

Unveiling Eli Lilly and Co (LLY)'s Value: Is It Really Priced Right? A Comprehensive Guide

Sep. 7, 2023 at 7:32 p.m. ET on GuruFocus.com

4 Expert Tips for Navigating a Gap Down Market

Sep. 7, 2023 at 12:53 p.m. ET on Zacks.com

Prothena (PRTA) Skyrockets 88.7% in 12 Months: Here's Why

Sep. 7, 2023 at 12:00 p.m. ET on Zacks.com

Why Is Lilly (LLY) Up 6.4% Since Last Earnings Report?

Sep. 7, 2023 at 11:30 a.m. ET on Zacks.com

3 Nasdaq Stocks to Sell in September Before They Crash & Burn

Sep. 7, 2023 at 8:41 a.m. ET on InvestorPlace.com

7 Pharma Stocks to Buy for Groundbreaking Treatments and Robust Revenue Growth

Sep. 7, 2023 at 7:08 a.m. ET on InvestorPlace.com

Berenberg Bank Sticks to Their Buy Rating for Eli Lilly & Co (LLY)

Sep. 6, 2023 at 9:55 p.m. ET on TipRanks.com

Should Franklin U.S. Large Cap Multifactor Index ETF (FLQL) Be on Your Investing Radar?

Sep. 6, 2023 at 6:20 a.m. ET on Zacks.com

Cantor Fitzgerald Keeps Their Buy Rating on Eli Lilly & Co (LLY)

Sep. 5, 2023 at 8:26 p.m. ET on TipRanks.com

The Latest Analyst Ratings for Eli Lilly

Sep. 5, 2023 at 4:00 p.m. ET on Benzinga.com

3 Forever Stocks to Buy With $100

Sep. 5, 2023 at 2:00 p.m. ET on Motley Fool

Novo Nordisk (NVO) Launches Wegovy in UK Amid Supply Issues

Sep. 5, 2023 at 1:52 p.m. ET on Zacks.com

Eli Lilly Unusual Options Activity For September 05

Sep. 5, 2023 at 10:46 a.m. ET on Benzinga.com

Competing in These 3 Markets Could Send Eli Lilly Stock Soaring

Sep. 5, 2023 at 10:00 a.m. ET on Motley Fool

3 Pharma Stocks Smart Money Is Following in September

Sep. 5, 2023 at 9:40 a.m. ET on StockNews.com

Here's 1 Stock That Could Join Apple and Amazon in the $1 Trillion Club That You Might Have Overlooked

Sep. 5, 2023 at 9:12 a.m. ET on Motley Fool

S&P 500 (SPY) ETF: What’s in the Cards?

Sep. 5, 2023 at 5:41 a.m. ET on TipRanks.com

(LLY) - Analyzing Eli Lilly's Short Interest

Sep. 4, 2023 at 10:00 a.m. ET on Benzinga.com

8 Pharma Stocks Affected by New Drug Price Negotiation Rules

Sep. 2, 2023 at 6:51 a.m. ET on Motley Fool

Lilly Endowment Inc Reduces Stake in Eli Lilly and Co

Lilly Endowment Inc Reduces Stake in Eli Lilly and Co

Sep. 2, 2023 at 3:01 a.m. ET on GuruFocus.com

No Headlines Available

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.

Name	Chg %	Market Cap
Johnson & Johnson	1.28%	$380.49B
Roche Holding AG	1.68%	CHF204.18B
Roche Holding AG Akt	1.61%	CHF204.18B
Pfizer Inc.	-0.26%	$194.05B
AbbVie Inc.	2.27%	$257.01B
Merck & Co. Inc.	1.36%	$270.22B
Novartis AG	1.63%	CHF173.84B
AstraZeneca PLC ADR	-1.72%	$205.31B
AstraZeneca PLC	2.06%	£164.38B
Sanofi S.A.	1.47%	€123.42B